X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
CADILA HEALTHCARE LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

CADILA HEALTHCARE LIMITED  (CADIL)


Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
cadila healthcare - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 453.0       No. of shares m 1,023.74
    Mkt Cap Rs m 463,703       % ch % 0.9
    Vol '000 84.2       % ch week % 2.5
    P/E X 34.0       % ch 1-mth % 2.9
    P/CF X 25.0       % ch 12-mth % 42.0
    EPS (TTM) Rs 13.3       52 week H/L Rs 460.0/305.0
(As on Mar 28, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs9849641,0791,763454 
Low Rs629695631872305 
Sales per share (Unadj.) Rs257.1310.5352.8422.596.1 
Earnings per share (Unadj.) Rs31.931.939.256.214.9 
Diluted earnings per shareRs6.46.47.811.214.9 
Cash flow per share (Unadj.) Rs39.640.949.170.217.8 
Dividends per share (Unadj.) Rs7.507.509.0012.003.20 
Adj. dividends per shareRs1.501.501.802.403.20 
Dividend yield (eoy) %0.90.91.10.90.8 
Book value per share (Unadj.) Rs126.3143.8168.0207.652.3 
Adj. book value per shareRs25.328.833.641.552.3 
Shares outstanding (eoy) m204.75204.75204.75204.751,023.74 
Bonus/Rights/Conversions  ----FV5:1 
Price / Sales ratio x3.12.72.43.13.9 
Avg P/E ratio x25.326.021.823.425.5 
P/CF ratio (eoy) x20.420.317.418.821.3 
Price / Book Value ratio x6.45.85.16.37.3 
Dividend payout %23.523.522.921.421.5 
Avg Mkt Cap Rs m165,131169,840175,061269,758388,458 
No. of employees `000NA12.212.213.215.4 
Total wages/salary Rs m7,5129,04210,71112,08513,317 
Avg. sales/employee Rs ThNM5,214.65,908.26,564.06,371.1 
Avg. wages/employee Rs ThNM741.6876.0916.9862.4 
Avg. net profit/employee Rs ThNM536.0657.2873.0986.1 
  INCOME DATA
Net Sales Rs m52,63363,57772,24086,51398,376 
Other income Rs m509370507554941 
Total revenues Rs m53,14263,94772,74787,06799,317 
Gross profit Rs m10,83911,25112,00117,59923,829 
Depreciation Rs m1,5791,8472,0122,8733,022 
Interest Rs m1,8271,687902679486 
Profit before tax Rs m7,9428,0879,59414,60121,262 
Minority Interest Rs m-286-364-326-397-300 
Prior Period Items Rs m0-13265425 
Extraordinary Inc (Exp) Rs m00-172-104-25 
Tax Rs m1,1301,1751,3252,6365,716 
Profit after tax Rs m6,5266,5358,03611,50615,226 
Gross profit margin %20.617.716.620.324.2 
Effective tax rate %14.214.513.818.126.9 
Net profit margin %12.410.311.113.315.5 
  BALANCE SHEET DATA
Current assets Rs m28,13031,91734,37942,26744,376 
Current liabilities Rs m21,91626,70428,14032,85134,071 
Net working cap to sales %11.88.28.610.910.5 
Current ratio x1.31.21.21.31.3 
Inventory Days Days7670696554 
Debtors Days Days6455576762 
Net fixed assets Rs m33,41037,61240,15341,50147,896 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m20,86023,82627,84537,86148,746 
Net worth Rs m25,85929,44534,39042,51653,519 
Long term debt Rs m13,22314,26013,62211,5048,964 
Total assets Rs m64,23073,74279,86590,471100,163 
Interest coverage x5.35.811.622.544.7 
Debt to equity ratio x0.50.50.40.30.2 
Sales to assets ratio x0.80.90.91.01.0 
Return on assets %13.011.111.213.515.7 
Return on equity %25.222.223.427.128.4 
Return on capital %24.321.521.427.434.3 
Exports to sales %25.824.327.732.545.3 
Imports to sales %6.76.45.86.25.9 
Exports (fob) Rs m13,56915,44220,03828,08044,537 
Imports (cif) Rs m3,5494,0734,2105,3915,838 
Fx inflow Rs m14,63616,23620,61329,66644,881 
Fx outflow Rs m5,0676,6206,8648,0939,069 
Net fx Rs m9,5699,61613,74921,57335,812 
  CASH FLOW
From Operations Rs m 5,111 6,034 9,028 9,936 19,938 
From Investments Rs m -11,995 -6,823 -4,380 -4,647 -9,039 
From Financial Activity Rs m 8,598 2,858 -5,287 -3,511 -9,527 
Net Cashflow Rs m 1,714 2,069 -639 1,778 1,372 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for cadila healthcare limited

 Share Holding
Indian Promoters : 74.8%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 8.3%
FIIs : 5.9%
ADR/GDR : 0.0%
Free float : 11.0%
Shareholders : 44,069
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: Zydus Tower, Satellite Cross Roads, Ahmedabad - 380 015
    E-MAIL: upen.shah@zyduscadila.com     WEB: www.zyduscadila.com
    TELEPHONE: (079) 2686 8326     FAX: (079) 2686 2365
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Sharepro Serv.,416-420, Devnandan Mall, Ellisbridge, Ahmedabad-09
    AUDITOR: Mukesh M. Shah & Co.
CHM: Pankaj R. Patel (MD) COMP SEC: Upen H. Shah YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 5 DIV YIELD (%): 0.7

More pharmaceuticals Company Fact Sheets:   INDOCO REMEDIESFRESENIUS KABI ONCO.AMAR REMEDIESMERCK LTDFDC LTD.


Today's Market

Sensex Closes up 172 Points; Axis Bank Soars 3.3%(Closing)

Indian share markets continued to witness buying momentum in the afternoon session. At the closing bell, the BSE Sensex stood higher by 172 points, while the NSE Nifty finished up by 56 points.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Doubled Your Money In D-Mart? Read This Before It's Too Late(Daily Profit Hunter)

Mar 22, 2017

Apurva breaks down the historic performance of initial public offerings in the context of D-Mart.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Why Mutual Fund Investors Should Not Worry About Market High. But...(Outside View)

Mar 22, 2017

PersonalFN provides a prudent investment strategy to invest in mutual funds as market scales a new high.

More

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - SUVEN LIFE COMPARISON

Compare Company With Charts

COMPARE CADILA HEALTHCARE WITH

MARKET STATS